Mélissa Degardin
- Molecular Biology
- Organic Chemistry
- Radiology, Nuclear Medicine and Imaging
- Oncology
- Materials Chemistry
- Co-authors
- Denis A. MalyshevFloyd E. RomesbergThomas LavergnePhillip OrdoukhanianLingjun LiDidier BoturynEric BusseronJulius Rebek
- Topics
- Radiopharmaceutical Chemistry and Applications (4 papers)Cell Adhesion Molecules Research (4 papers)Cancer, Hypoxia, and Metabolism (3 papers)
- Partner nations
- FranceUnited StatesJapan
In The Last Decade
Mélissa Degardin
21 papers receiving 408 citations
Peers
Comparison fields: 5 of 71
- Molecular Biology 210
- Organic Chemistry 90
- Radiology, Nuclear Medicine and Imaging 58
- Oncology 43
- Materials Chemistry 40
Countries citing papers authored by Mélissa Degardin
This map shows the geographic impact of Mélissa Degardin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mélissa Degardin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mélissa Degardin more than expected).
Fields of papers citing papers by Mélissa Degardin
This network shows the impact of papers produced by Mélissa Degardin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mélissa Degardin. The network helps show where Mélissa Degardin may publish in the future.
Co-authorship network of co-authors of Mélissa Degardin
This figure shows the co-authorship network connecting the top 25 collaborators of Mélissa Degardin. A scholar is included among the top collaborators of Mélissa Degardin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mélissa Degardin. Mélissa Degardin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 11 | |
| 4 | 26 | |
| 5 | 11 | |
| 6 | 23 | |
| 7 | 6 | |
| 8 | 8 | |
| 9 | 37 | |
| 10 | 6 | |
| 11 | 13 | |
| 12 | 8 | |
| 13 | 32 | |
| 14 | 132 | |
| 15 | 42 | |
| 16 | 6 | |
| 17 | 12 | |
| 18 | 11 | |
| 19 | [LY231514. A multitargeted antifolate (MTA)]. | 1 |
| 20 | [Multicenter prospective study of cardiac accidents during treatments with 5-FU]. | 3 |
About Mélissa Degardin
Mélissa Degardin is a scholar working on Immunology and Allergy, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 22 papers that have together received 408 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (4 papers), Cell Adhesion Molecules Research (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). The work is most often cited by research in Immunology and Allergy (28 citations), Organic Chemistry (90 citations) and Molecular Biology (210 citations). Mélissa Degardin has collaborated with scholars based in France, United States and Japan. Frequent co-authors include Denis A. Malyshev, Floyd E. Romesberg, Thomas Lavergne, Phillip Ordoukhanian, Lingjun Li, Didier Boturyn, Eric Busseron, Julius Rebek, Jacques Lux and Atsushi B. Tsuji. Their work appears in journals such as Journal of the American Chemical Society, Chemical Communications and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.